Key Influencer in the Biologic Imaging Reagents Market 2025: Chronic Disease Prevalence Fuels Growth of Biologic Imaging Reagents Market Driver

How Are the key drivers contributing to the expansion of the biologic imaging reagents market?
As the prevalence of chronic diseases continues to rise, it is anticipated that the biologic imaging reagents market will enjoy substantial growth. Chronic diseases are those that persist for at least a year and necessitate sustained medical attention, often worsening over time. Biologic imaging reagents facilitate the visualisation of organs and affected structures, making it possible to diagnose and detect these diseases. For example, in 2022, the American Cancer Society predicted that there would be 1.9 million new diagnoses of cancer and 609,360 cancer-related deaths in the United States. Furthermore, in January 2023, the National Library of Medicine reported that the number of people aged 50 and older in the US with a chronic condition was projected to surge by 99.5%, from 71.522 million to 142.66 million by 2050. Consequently, the escalating prevalence of chronic diseases is fuelling the expansion of the biologic imaging reagents market. The demand for personalized medicine is also expected to accelerate the growth of the biologic imaging reagents market. Personalized medicine is a healthcare approach that customises medical treatment and decision-making to the unique characteristics of each patient. Biologic imaging reagents play an integral role in personalized medicine by enabling the visualization and examination of biological processes at a molecular and cellular level, adjusting to individual patients' needs. In 2022, the US-based Personalized Medicine Coalition announced that the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Of these 35 therapeutic NMEs, around 34%, or 12, were classified as personalized medicines by the PMC. As such, the increasing demand for personalized medicine is contributing to the growth of the biologic imaging reagents market.

Get Your Biologic Imaging Reagents Market Report Here:
https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report

What growth opportunities are expected to drive the biologic imaging reagents market's CAGR through 2034?
The market size of biologic imaging reagents has seen a swift expansion in recent years. From $18.41 billion in 2024, it is projected to increase to $20.26 billion in 2025 with a compound annual growth rate (CAGR) of 10.0%. The surge experienced in the past period is credited to the escalation in chronic disease prevalence, the increase in research and development funding, the trend towards personalized medicine, a spotlight on initial disease discovery, a swelling elderly populace, and partnerships in biomedical research.

The market for biologic imaging reagents is projected to experience robust growth in the coming years, expanding to $27.78 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This anticipated growth in the forecast period can be linked to factors such as the broader applications in drug development, increasing need for molecular imaging, focus on non-invasive diagnostic techniques, a worldwide rise in cancer incidents, and a shift towards value-based healthcare. Key trends expected during the forecast period include growing demand for contrast-enhanced imaging agents, advancements in targeted molecular imaging agents, use of nanoparticles in imaging techniques, the advent of fluorescent probes for in vivo imaging, and the incorporation of artificial intelligence in image analysis.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp

What are the most significant trends transforming the biologic imaging reagents market today?
Key players in the biologic imaging reagents market are honing their focus on the creation of new and innovative reagents, such as pioneering dye technology. This provides researchers and clinicians with an advanced tool for enhancing the accuracy and detection rate of biologic imaging. The innovative dye technology involves the generation of new dyes designed for an array of applications, including biological imaging. Take, for example, Becton, Dickinson, and Company, who in April 2022, introduced the BD Horizon RealYellow 586 Reagents and RealBlue Reagents to the market. This new group of reagents provides researchers with the ability to garner higher data resolution and glean more information from their samples compared to conventional fluorochrome. Such an advancement was made possible thanks to the application of breakthrough dye technology along with the supervision of artificial intelligence (AI). Using AI, existing data from excitation and emission profiles of commercially available fluorochromes were analyzed and the optimal locations in laser lines were determined for the creation of these innovative dyes.

Which growth-oriented segments of the biologic imaging reagents market are leading the industry's development?
The biologic imaging reagents market covered in this report is segmented -

1) By Product: Contrast Reagents, Optical Imaging Reagents, Radiopharmaceuticals
2) By Modality: Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray And Computerized Tomography (CT), Nuclear, Optical Imaging, Other Modalities
3) By Application: In Vitro, In Vivo
4) By End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research And Academic Institutes, Other End Users

Subsegments:
1) By Contrast Reagents: X-ray Contrast Agents, MRI Contrast Agents, Ultrasound Contrast Agents
2) By Optical Imaging Reagents: Fluorescent Dyes, Bioluminescent Reagents, Quantum Dots
3) By Radiopharmaceuticals: Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13389

What regions are leading the charge in the biologic imaging reagents market?
North America was the largest region in the biologic imaging reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the biologic imaging reagents market?
Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp

What Is Covered In The Biologic Imaging Reagents Global Market Report?

• Market Size Forecast: Examine the biologic imaging reagents market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the biologic imaging reagents market for a structured understanding.
• Key Players Overview: Analyze major players in the biologic imaging reagents market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the biologic imaging reagents market.
• Segment Contributions: Evaluate how different segments drive overall growth in the biologic imaging reagents market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the biologic imaging reagents market.
• Industry Challenges: Identify potential risks and obstacles affecting the biologic imaging reagents market.
• Competitive Landscape: Review strategic developments in the biologic imaging reagents market, including expansions, agreements, and new product launches.

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.